Tag Archives: orange book

Cutting Through the Patent Thicket – The Little Bill that Couldn’t

A bill was recently proposed to “reduce the improper issuance of patents that improperly extend the term of exclusivity afforded a new drug or biological product.” The bill would amend the patent statutes (s. 253 or title 35) for add … Continue reading

Posted in Drug Patent Term | Tagged , , , , , | Leave a comment

“We Don’t Need No Stinkin’ Patents” – Antibiotic and Antifungal Drugs Gain Non-Patent Exclusivity

Posted on the FDA Law Blog by Kurt Karst on June 19, 2014. After years of relative quiet, the Orange Book list of exclusivity terms has gotten quite a workout over the past year with the addition of several new terms … Continue reading

Posted in Hatch-Waxman | Tagged , , , , , , | Leave a comment

Get Your Application On The Fast Track – For A Price

On Friday, the PTO proposed changes in the rules to permit applicants for U.S. patents to receive “prioritized examination” (76 Fed. Reg. 6370 (Feb. 4 2011) – a copy is attached below). This program is a remnant of the three-track … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , , , , , , | Leave a comment